| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06.11. | Guardian Pharmacy forecasts $1.44B-$1.46B 2026 revenue and $136M-$138M adjusted EBITDA as it expands in Texas and Alabama | 1 | Seeking Alpha | ||
| 06.11. | Guardian Pharmacy Services Non-GAAP EPS of $0.33 beats by $0.02, revenue of $371.1M beats by $5.34M | 2 | Seeking Alpha | ||
| 05.11. | Guardian Pharmacy Services, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 12.10. | Transcript: Guardian Pharmacy Service Q2 2026 Earnings Conference Call | 1 | Benzinga.com | ||
| GUARDIAN PHARMACY SERVICES Aktie jetzt für 0€ handeln | |||||
| 15.09. | Guardian Pharmacy Services Aktie erreicht Rekordhoch von 47,05 USD | 1 | Investing.com Deutsch | ||
| 01.09. | Guardian Pharmacy acquires assets from Nautilus Pharmacy | 2 | Investing.com | ||
| 01.09. | Guardian Pharmacy übernimmt Vermögenswerte von Nautilus Pharmacy | 2 | Investing.com Deutsch | ||
| 07.08. | Guardian Pharmacy Services: Aktie nach starken Quartalszahlen und Prognoseerhöhung im Aufwind | 1 | Investing.com Deutsch | ||
| 07.08. | Guardian Pharmacy Services Non-GAAP EPS of $0.29 beats by $0.03, revenue of $351.8M beats by $11.35M | 2 | Seeking Alpha | ||
| 06.08. | Guardian Pharmacy hebt nach Margensteigerung im 2. Quartal den Ausblick für 2026 an | 4 | Investing.com Deutsch | ||
| 06.08. | Guardian Pharmacy Services, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 22.06. | Guardian Pharmacy names new COO and CFO as executive retires | 1 | Investing.com | ||
| 22.06. | Führungswechsel bei Guardian Pharmacy: COO und CFO neu besetzt | 1 | Investing.com Deutsch | ||
| 22.06. | Guardian Pharmacy announces COO and CFO succession | 1 | Seeking Alpha | ||
| 22.06. | Guardian Pharmacy Services, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 17.06. | Truist raises Guardian Pharmacy stock price target on growth outlook | 1 | Investing.com | ||
| 09.06. | Aktie von Guardian Pharmacy Services erreicht Rekordhoch bei 41,81 USD | 1 | Investing.com Deutsch | ||
| 28.05. | Guardian Pharmacy Services, Inc. - 8-K, Current Report | 1 | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEARTFLOW | 59,86 | 0,00 % | HeartFlow Q3 2026 Earnings Preview | ||
| BRIGHTSPRING HEALTH SERVICES | 71,46 | 0,00 % | BrightSpring, Centene stand out as healthcare's most persistent Strong Buys | ||
| AVEANNA HEALTHCARE | 12,225 | -6,61 % | Aveanna outlines 2026 revenue >$2.695B and adjusted EBITDA >$374M as preferred payer strategy expands | ||
| LIFESTANCE HEALTH GROUP | 14,150 | 0,00 % | LifeStance Health Prices Secondary Public Offering Of 45 Mln Shares At $13.12/Shr | ||
| GENEDX | 51,89 | -5,37 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced that company management will participate in upcoming investor conferences:... ► Artikel lesen | |
| STARLING ONCOLOGY INSTITUTE | 3,720 | 0,00 % | Starling Oncology expects $650M-$660M revenue and $4M-$6M adjusted EBITDA in 2026 while targeting 100% capitated revenue growth in 2027 | ||
| ADAPTHEALTH | 7,880 | +1,03 % | AdaptHealth auf der UBS Global Healthcare Conference: Trendwende bei Kaiser Permanente leitet Konsolidierungsphase ein | ||
| PHAOS TECHNOLOGY | 2,980 | 0,00 % | Phaos Technology Holdings (Cayman) Limited Announces One-For-Fifteen Reverse Stock Split | SINGAPORE, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Phaos Technology Holdings (Cayman) Limited, (NYSE American: POAS), ("Phaos" or "the Company"), an advanced microscopy solutions headquartered in Singapore... ► Artikel lesen | |
| OPTIMIZERX | 8,600 | 0,00 % | Stifel senkt Kursziel für OptimizeRx nach Umsatzrückgang auf 11 Dollar | ||
| CLEARPOINT NEURO | 8,475 | 0,00 % | ClearPoint Neuro: Operatives Momentum, neue Partnerschaften und Turnaround-Hoffnung für Spezialanbieter im Neuro-Markt | ClearPoint Neuro gewinnt an operativem Momentum: Das Unternehmen verzeichnet wachsendes Interesse in mehreren Geschäftssparten, treibt die Kommerzialisierung seiner Technologieplattform voran und positioniert... ► Artikel lesen | |
| AGILON HEALTH | 110,46 | -3,77 % | StoneX raises agilon health stock price target to $145 on guidance | ||
| ARDENT HEALTH | 17,665 | 0,00 % | Ardent Health to buy Boone Health for purchase price of $47M in cash | ||
| MIMEDX | 3,235 | -4,01 % | MiMedx Group, Inc: MIMEDX Announces Favorable Federal Court Ruling in AXIOFILL Regulatory Classification Matter | Court Vacates FDA Determinations That AXIOFILL Is Not Minimally Manipulated and Should Be Classified as a Biological Product Order Further Holds That Minimal-Manipulation Analysis Must Consider Tissue... ► Artikel lesen | |
| QTREX QUANTUM | 1,185 | 0,00 % | QTREX Quantum Ltd.: QTREX Quantum Reaffirms October 1 Disclosure and Expects Multiple Additional Commercial Agreements in the Fourth Quarter of 2026 | ||
| INNOVAGE | 9,400 | 0,00 % | InnovAge Announces Financial Results for the Fourth Quarter and Fiscal Year Ended June 30, 2026 | DENVER, Sept. 08, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly... ► Artikel lesen |